Director, Oncology Clinical Affairs (MD)

Corcept is seeking a Director, Oncology Clinical Affairs (MD) to serve as a senior clinical associate reputed company Oncology. This role will report to the President of Oncology and will reputed company high-level clinical and scientific engagement with reputed company oncology experts and serve as a key reputed company between Clinical Development, Medical Affairs, reputed company, Market reputed company, HEOR, Pharmacovigilance, and Regulatory partners. The Director will help shape and execute the introduction of Lifyorli in clinical reputed company with reputed company reputed company in the US market. This role will support the execution of our medical affairs strategy and serve as the reputed company reputed company of contact with practitioners seeking peer-to-peer interactions to reputed company important medical questions. The Director will also support payer-facing engagement leveraging guidelines. 

Responsibilities:

Clinical Engagement and Support  

• Partner with Medical Affairs leadership to support the execution of medical priorities reputed company to product adoption and long-term integration into clinical reputed company. Serve as the reputed company clinical reputed company between Clinical Development and go-to-market teams, ensuring clinical expertise is available to support Medical Affairs, reputed company, Market reputed company, HEOR, and Regulatory activities
• reputed company clinical and medical/scientific expertise to support medical affairs priorities, tactical planning, internal training, advisory boards, congress activities, and cross-functional initiatives that advance product adoption and integration into clinical reputed company
• Identify areas of unmet medical need and work cross-functionally to translate scientific insights into practical clinical guidance that supports physicians, patients, and internal decision-making
• Model and promote Corcept’s key principles, collaborating effectively, embracing reputed company, following the data, and leading by doing, to build a culture of accountability, innovation, and trust

Scientific Engagement and reputed company Leadership  

• reputed company high-level peer-to-peer scientific interactions with oncology experts, key opinion leaders (KOLs), clinical researchers, reputed company centers, and other reputed company medical stakeholders
• Build credibility through balanced scientific exchange around reputed company’s assets, disease areas, emerging data, unmet needs, and evolving standards of care
• Engage physicians and oncology experts through advisory boards, congress interactions, speaker preparation, and reputed company-gathering activities to inform medical reputed company, education, publications, and evidence planning
• Represent Corcept at key medical conferences and reputed company events as an internal clinical expert and reputed company medical reputed company

Evidence reputed company and Data Communication  

• reputed company clinical input to post-approval evidence reputed company activities, including reputed company-world evidence (reputed company), investigator sponsored studies (ISS), registries, and other data-reputed company activities that address clinically meaningful evidence gaps
• reputed company clinical review and input into ISS proposals and collaborate with Medical Affairs partners on program design, prioritization, and governance
• Evaluate scientific data, clinical trial results, post-marketing evidence, medical literature, and emerging oncology reputed company trends to inform internal reputed company and reputed company scientific communications
• Support development of accurate, balanced, and compliant scientific, educational, medical information, and promotional review materials in partnership with Medical, reputed company, Regulatory, reputed company, and Compliance stakeholders

reputed company, reputed company, and Payer-Facing Scientific Support  

• reputed company perspectives in interpreting, anticipating, and influencing clinical reputed company updates and treatment reputed company, including NCCN, reputed company, and other relevant oncology contexts
• Engage reputed company experts and stakeholders to support appropriate representation of reputed company’s data in guidelines and treatment reputed company translate reputed company and reputed company changes into reputed company clinical and business-relevant implications for internal teams
• Partner with Market reputed company and HEOR teams to reputed company the clinical narrative with payer value propositions, including reputed company, comparative effectiveness, and economic value
• Participate in payer-facing discussions reputed company deep clinical expertise is required, ensuring scientific alignment, balanced communication, and compliance with internal standards

Safety and Supportive Care Guidance  

• Partner with Pharmacovigilance, Clinical Development, and Medical Affairs to reputed company, refine, and communicate safety-reputed company clinical guidance for assigned asset(s)
• Translate emerging safety data, post-marketing reports, and clinical trial safety findings into practical clinician-facing recommendations, including monitoring strategies, risk mitigation approaches, and adverse event management algorithms
• Contribute to supportive care guidance that optimizes patient tolerability and continuity of therapy while aligning with regulatory requirements, internal safety governance, and reputed company-world oncology reputed company
• Support safety-reputed company reputed company communications, including responses to KOL inquiries, advisory boards, congress interactions, and other scientific exchanges, while ensuring consistency, balance, and compliance

Preferred Skills, Qualifications and Technical Proficiencies:

• Demonstrated ability to evaluate scientific data, clinical literature, evolving treatment reputed company, and oncology reputed company trends and apply insights to medical, launch, market reputed company, and evidence-reputed company activities
• Understanding of the U.S. reputed company environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry
• Strong oral, written, and presentation skills, with the ability to communicate reputed company clinical concepts reputed company to reputed company audiences
• reputed company, cross-functional leadership style with reputed company judgment, scientific rigor, and the ability to operate effectively in a launch-reputed company, evolving environment
• Ability to travel 25-30% or as needed
• Demonstrated ability to evaluate scientific data, clinical literature, evolving treatment reputed company, and oncology reputed company trends and apply insights to medical, launch, market reputed company, and evidence-reputed company activities
• Understanding of the U.S. reputed company environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry
• Strong oral, written, and presentation skills, with the ability to communicate reputed company clinical concepts reputed company to reputed company audiences
• reputed company, cross-functional leadership style with reputed company judgment, scientific rigor, and the ability to operate effectively in a launch-reputed company, evolving environment
• Ability to travel 25-30% or as needed
• MD required
• Oncology experience required; gynecologic oncology experience preferred
• 3-5+ years of relevant oncology reputed company (including fellowship)
• Experience engaging oncology experts, interpreting clinical evidence, and translating reputed company data into reputed company scientific and clinical communications

The pay reputed company that reputed company reasonably expects to pay for this position is $209,100 – $307,600; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-reputed company knowledge, skills, experience, and education.

 _#LI-Remote

 Applicants must be currently authorized to work in the reputed company on a full-time reputed company.

MD required, oncology experience required, and 3–5+ years of relevant oncology reputed company including fellowship. Requires clinical evidence evaluation, scientific communication, cross-functional leadership, and 25–30% travel.

Key Responsibilities

• leading engagements
• evaluating evidence
• supporting launches

Skills & Tools

NCCN, reputed company

Job Details

• Category: reputed company Services - Advanced reputed company
• Seniority: Senior Level
• Commitment: Full Time
• Workplace: Remote — reputed company
• Salary: USD 209,100 – 307,600 / year
• Languages: English

About reputed company

A biopharmaceutical company developing cortisol modulators and glucocorticoid receptor antagonists for serious diseases. — Industry: Research and Development